0000950157-23-001058.txt : 20231017 0000950157-23-001058.hdr.sgml : 20231017 20231017090656 ACCESSION NUMBER: 0000950157-23-001058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20231017 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231017 DATE AS OF CHANGE: 20231017 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THERMO FISHER SCIENTIFIC INC. CENTRAL INDEX KEY: 0000097745 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 042209186 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08002 FILM NUMBER: 231328571 BUSINESS ADDRESS: STREET 1: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 7816221000 MAIL ADDRESS: STREET 1: 168 THIRD AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: THERMO ELECTRON CORP DATE OF NAME CHANGE: 19920703 8-K 1 form8-k.htm CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 17, 2023

THERMO FISHER SCIENTIFIC INC.
(Exact name of Registrant as specified in its Charter)

Delaware
001-08002
04-2209186
(State of incorporation)
(Commission File Number)
(I.R.S. Employer Identification Number)

168 Third Avenue
Waltham, Massachusetts 02451
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (781) 622-1000

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common Stock, $1.00 par value
 
TMO
 
New York Stock Exchange
0.750% Notes due 2024
 
TMO 24A
 
New York Stock Exchange
0.125% Notes due 2025
 
TMO 25B
 
New York Stock Exchange
2.000% Notes due 2025
 
TMO 25
 
New York Stock Exchange
1.400% Notes due 2026
 
TMO 26A
 
New York Stock Exchange
3.200% Notes due 2026
 
TMO 26B
 
New York Stock Exchange
1.450% Notes due 2027
 
TMO 27
 
New York Stock Exchange
1.750% Notes due 2027
 
TMO 27B
 
New York Stock Exchange
0.500% Notes due 2028
 
TMO 28A
 
New York Stock Exchange
1.375% Notes due 2028
 
TMO 28
 
New York Stock Exchange
1.950% Notes due 2029
 
TMO 29
 
New York Stock Exchange
0.875% Notes due 2031
 
TMO 31
 
New York Stock Exchange
2.375% Notes due 2032
 
TMO 32
 
New York Stock Exchange
3.650% Notes due 2034
 
TMO 34
 
New York Stock Exchange
2.875% Notes due 2037
 
TMO 37
 
New York Stock Exchange
1.500% Notes due 2039
 
TMO 39
 
New York Stock Exchange
1.875% Notes due 2049
 
TMO 49
 
New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or (§230.405 of this chapter) Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
   Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 








Item 8.01
Other Events

On October 17, 2023, Thermo Fisher Scientific Inc. (“Thermo Fisher”) and Olink Holding AB (publ) (“Olink”) issued a joint press release announcing the execution of a Purchase Agreement by and between Thermo Fisher and Olink, pursuant to which, upon the terms and subject to the conditions thereof, Thermo Fisher or a subsidiary of Thermo Fisher will commence a tender offer to purchase all of the outstanding common shares and American Depositary Shares of Olink. A copy of the joint press release is attached as Exhibit 99.1 hereto and is incorporated herein by reference.


Item 9.01
Financial Statements and Exhibits

(d) Exhibits

Exhibit
No.
 
Description of Exhibit
 
 

104
 
Cover Page Interactive Data File (embedded with the Inline XBRL document)


Forward-Looking Statements

This communication contains forward-looking statements that involve a number of risks and uncertainties. Words such as “believes,” “anticipates,” “plans,” “expects,” “seeks,” “estimates,” and similar expressions are intended to identify forward-looking statements, but other statements that are not historical facts may also be deemed to be forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the COVID-19 pandemic, the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general economic conditions and related uncertainties; dependence on customers’ capital spending policies and government funding policies; the effect of economic and political conditions and exchange rate fluctuations on international operations; use and protection of intellectual property; the effect of changes in governmental regulations; any natural disaster, public health crisis or other catastrophic event; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to recent or pending acquisitions, including the proposed acquisition, may not materialize as expected; the proposed acquisition not being timely completed, if completed at all; regulatory approvals required for the transaction not being timely obtained, if obtained at all, or being obtained subject to conditions; prior to the completion of the transaction, Olink’s business experiencing disruptions due to transaction-related uncertainty or other factors making it more difficult to maintain relationships with employees, customers, licensees, other business partners or governmental entities; difficulty retaining key employees; the outcome of any legal proceedings related to the proposed acquisition; and the parties being unable to successfully implement integration strategies or to achieve expected synergies and operating efficiencies within the expected time-frames or at all. Additional important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in Thermo Fisher’s Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q, which are on file with the U.S. Securities and Exchange Commission (“SEC”) and available in the “Investors” section of Thermo Fisher’s website, ir.thermofisher.com, under the heading “SEC Filings”, and in any subsequent documents Thermo Fisher files or furnishes with the SEC, and in Olink’s Annual Report on Form 20-F and subsequent interim reports on Form 6-K, which are on file with the SEC and available in the “Investor Relations” section of Olink’s website, https://investors.olink.com/investor-relations, under the heading “SEC Filings”, and in any subsequent documents Olink files or furnishes with the SEC. While Thermo Fisher or Olink may elect to update forward-looking statements at some point in the future, Thermo Fisher and Olink specifically disclaim any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing either Thermo Fisher’s or Olink’s views as of any date subsequent to today.

Additional Information and Where to Find It

The tender offer referenced herein has not yet commenced. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any shares of Olink or any other securities, nor is it a substitute for the tender offer materials that Thermo Fisher or its acquisition subsidiary will file with the SEC. The terms and conditions of the tender offer will be published in, and the offer to purchase ordinary shares of Olink will be made only pursuant to, the offer document and related offer materials prepared by Thermo Fisher and its acquisition subsidiary and filed with the SEC in a tender offer statement on Schedule TO at the time the tender offer is commenced.  Olink intends to file a solicitation/recommendation statement on Schedule 14D-9 with the SEC with respect to the tender offer.

THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9, AS THEY MAY BE AMENDED FROM TIME TO TIME, WILL CONTAIN IMPORTANT INFORMATION.  INVESTORS AND SHAREHOLDERS OF OLINK ARE URGED TO READ THESE DOCUMENTS CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY, AND NOT THIS DOCUMENT, WILL GOVERN THE TERMS AND CONDITIONS OF THE TENDER OFFER, AND BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT SUCH PERSONS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR COMMON SHARES AND AMERICAN DEPOSITARY SHARES.

The tender offer materials, including the offer to purchase and the related letter of transmittal and certain other tender offer documents, and the solicitation/recommendation statement (when they become available) and other documents filed with the SEC by Thermo Fisher or Olink, may be obtained free of charge at the SEC’s website at www.sec.gov or at Olink’s website at investors.olink.com/investor-relations or at Thermo Fisher’s website at www.thermofisher.com or by contacting Thermo Fisher’s investor relations department at 781-622-1111. In addition, Thermo Fisher’s tender offer statement and other documents it will file with the SEC will be available at https://ir.thermofisher.com/investors.




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

   
THERMO FISHER SCIENTIFIC INC.
       
       
Date:
October 17, 2023
By:
/s/ Michael A. Boxer
 
 
 
Michael A. Boxer
 
 
 
Senior Vice President and General Counsel


EX-99.1 2 ex99-1.htm PRESS RELEASE
Exhibit 99.1


Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics

Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions

Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportunities

WALTHAM, Mass. and UPPSALA, Sweden – October 17, 2023 – Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, and Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions, today announced that their respective boards of directors have approved Thermo Fisher’s proposal to acquire Olink for $26.00 per common share in cash, representing $26.00 per American Depositary Share (ADS) in cash. This represents a premium of approximately 74% to the closing price of Olink’s American Depositary Shares that trade on NASDAQ on October 16, 2023, the last trading day prior to the announcement of the transaction. Thermo Fisher will commence a tender offer to acquire all of the outstanding Olink common shares and all of the American Depositary Shares. The transaction values Olink at approximately $3.1 billion which includes net cash of approximately $143 million.

Olink offers leading solutions for advanced proteomics discovery and development, enabling biopharmaceutical companies and leading academic researchers to gain an understanding of disease at the protein level rapidly and efficiently. Olink’s proprietary technology, Proximity Extension Assay (PEA), provides high throughput protein analysis for the very large installed base of qPCR and next-generation sequencing readout systems in the market. With a library of more than 5,300 validated protein biomarker targets, adoption of the technology has been very strong, leading to over 1,400 scientific publications. Headquartered in Sweden, Olink has operations in the Americas, Europe and Asia Pacific.

“The acquisition of Olink underscores the profound impact that proteomics is having as our customers continue to advance life science research and precision medicine,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. “Olink’s proven and transformative innovation is highly complementary to our leading mass spectrometry and life sciences platforms. Our company is uniquely positioned to bring this technology to customers enabling them to meaningfully accelerate discovery and scientific breakthroughs. We look forward to welcoming Olink’s colleagues to Thermo Fisher.”

Jon Heimer, CEO of Olink said, “Olink is dedicated to improving the understanding of human biology by accelerating the use of next-generation proteomics and providing industry-leading data quality at unprecedented scale. Thermo Fisher’s deep life sciences expertise, global reach and proven operational excellence will enable significant opportunities for both customers and colleagues, while also providing immediate value to our shareholders.”

The transaction, which is expected to be completed by mid-2024, is subject to customary closing conditions, including receipt of applicable regulatory approvals, and completion of the tender offer. As part of the transaction, Summa Equity AB, Olink’s largest shareholder and additional Olink shareholders and management, in aggregate holding more than 63% of Olink’s common shares, have entered into support agreements agreeing to tender into the tender offer. Thermo Fisher expects to fund the acquisition using cash on hand and debt financing. Upon completion, Olink will become part of Thermo Fisher’s Life Sciences Solutions segment.




Olink is on track to deliver over $200M of revenue in 2024 and, as part of Thermo Fisher, is expected to grow mid-teens organically. In the first full year of ownership, the transaction is expected to be dilutive to adjusted EPS1 by $0.17. Excluding financing costs and non-cash deal related equity compensation costs, the transaction is expected to be accretive by $0.10 in that period. Thermo Fisher expects to realize approximately $125 million of adjusted operating income1 from revenue and cost synergies by year five following close. The expected strong long-term business growth and synergy realization profile make the financial returns on the transaction very compelling.

Advisors

For Thermo Fisher, Cravath, Swaine & Moore LLP and Advokatfirman Vinge KB are serving as legal counsel. For Olink, J.P. Morgan Securities LLC is serving as lead financial advisor, Goldman Sachs Bank Europe SE, Sweden Bankfilial is serving as financial advisor and Baker & McKenzie is serving as legal counsel.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

About Olink

Olink Holding AB (publ)(Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major pharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.




1 Adjusted earnings per share and adjusted operating income are non-GAAP measures that exclude certain items detailed later in this press release under the heading “Use of Non-GAAP Financial Measures.”



Forward-looking Statements

This press release contains forward-looking statements that involve a number of risks and uncertainties. Words such as “believes,” “anticipates,” “plans,” “expects,” “seeks,” “estimates,” and similar expressions are intended to identify forward-looking statements, but other statements that are not historical facts may also be deemed to be forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the COVID-19 pandemic, the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general economic conditions and related uncertainties; dependence on customers’ capital spending policies and government funding policies; the effect of economic and political conditions and exchange rate fluctuations on international operations; use and protection of intellectual property; the effect of changes in governmental regulations; any natural disaster, public health crisis or other catastrophic event; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to recent or pending acquisitions, including the proposed  acquisition, may not materialize as expected; the proposed acquisition not being timely completed, if completed at all; regulatory approvals required for the transaction not being timely obtained, if obtained at all, or being obtained subject to conditions; prior to the completion of the transaction, Olink’s business experiencing disruptions due to transaction-related uncertainty or other factors making it more difficult to maintain relationships with employees, customers, licensees, other business partners or governmental entities; difficulty retaining key employees; the outcome of any legal proceedings related to the proposed acquisition; and the parties being unable to successfully implement integration strategies or to achieve expected synergies and operating efficiencies within the expected time-frames or at all. Additional important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in Thermo Fisher’s Annual Report on Form 10-K and subsequent quarterly reports on Form 10-Q, which are on file with the U.S. Securities and Exchange Commission (“SEC”) and available in the “Investors” section of Thermo Fisher’s website, ir.thermofisher.com, under the heading “SEC Filings”, and in any subsequent documents Thermo Fisher files or furnishes with the SEC, and in Olink’s Annual Report on Form 20-F and subsequent interim reports on Form 6-K, which are on file with the SEC and available in the “Investor Relations” section of Olink’s website, https://investors.olink.com/investor-relations, under the heading “SEC Filings”, and in any subsequent documents Olink files or furnishes with the SEC. While Thermo Fisher or Olink may elect to update forward-looking statements at some point in the future, Thermo Fisher and Olink specifically disclaim any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing either Thermo Fisher’s or Olink’s views as of any date subsequent to today.

Additional Information and Where to Find It

The tender offer referenced herein has not yet commenced. This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell any common shares or American Depositary Shares of Olink or any other securities, nor is it a substitute for the tender offer materials that Thermo Fisher or its acquisition subsidiary will file with the SEC. The terms and conditions of the tender offer will be published in, and the offer to purchase common shares and American Depositary Shares of Olink will be made only pursuant to, the offer document and related offer materials prepared by Thermo Fisher and its acquisition subsidiary and filed with the SEC in a tender offer statement on Schedule TO at the time the tender offer is commenced.  Olink intends to file a solicitation/recommendation statement on Schedule 14D-9 with the SEC with respect to the tender offer.

THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9, AS THEY MAY BE AMENDED FROM TIME TO TIME, WILL CONTAIN IMPORTANT INFORMATION.  INVESTORS AND SHAREHOLDERS OF OLINK ARE URGED TO READ THESE DOCUMENTS CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY, AND NOT THIS DOCUMENT, WILL GOVERN THE TERMS AND CONDITIONS OF THE TENDER OFFER, AND BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT SUCH PERSONS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR COMMON SHARES AND AMERICAN DEPOSITARY SHARES.

The tender offer materials, including the offer to purchase and the related letter of transmittal and certain other tender offer documents, and the solicitation/recommendation statement (when they become available) and other documents filed with the SEC by Thermo Fisher or Olink, may be obtained free of charge at the SEC’s website at www.sec.gov or at Olink’s website at https://investors.olink.com/investor-relations or at Thermo Fisher’s website at www.thermofisher.com or by contacting Thermo Fisher’s investor relations department at 781-622-1111.  In addition, Thermo Fisher’s tender offer statement and other documents it will file with the SEC will be available at https://ir.thermofisher.com/investors





Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), Thermo Fisher uses certain non-GAAP financial measures, including adjusted earnings per share and adjusted operating margin, which exclude certain acquisition-related costs, including charges for the sale of inventories revalued at the date of acquisition and significant transaction costs; restructuring and other costs/income; amortization of acquisition-related intangible assets; certain other gains and losses that are either isolated or cannot be expected to occur again with any regularity or predictability, tax provisions/benefits related to the previous items, benefits from tax credit carryforwards, the impact of significant tax audits or events, equity in earnings of unconsolidated entities and the results of discontinued operations, as applicable. Thermo Fisher excludes the above items because they are outside of the company’s normal operations and/or, in certain cases, are difficult to forecast accurately for future periods. Thermo Fisher believes that the use of non-GAAP measures helps investors to gain a better understanding of the company’s core operating results and future prospects, consistent with how management measures and forecasts the company’s performance, especially when comparing such results to previous periods or forecasts.


EX-101.SCH 3 tmo-20231017.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 tmo-20231017_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 tmo-20231017_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Common Stock [Member] Class of Stock [Domain] Class of Stock [Axis] Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Entity Listings [Table] Entity Listings [Line Items] Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name 1.400% Notes due 2026 [Member] 3.650% Notes due 2034 [Member] 1.875% Notes due 2049 [Member] 0.875% Notes due 2031 [Member] 1.375% Notes due 2028 [Member] 1.500% Notes due 2039 [Member] 0.500% Notes due 2028 [Member] 1.450% Notes due 2027 [Member] 3.200% Notes due 2026 [Member] 0.125% Notes due 2025 [Member] 1.750% Notes due 2027 [Member] 1.950% Notes due 2029 [Member] 2.875% Notes due 2037 [Member] 2.375% Notes due 2032 [Member] 2.000% Notes due 2025 [Member] 0.750% Notes due 2024 [Member] EX-101.PRE 6 tmo-20231017_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document and Entity Information
Oct. 17, 2023
Entity Listings [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 17, 2023
Entity File Number 001-08002
Entity Registrant Name THERMO FISHER SCIENTIFIC INC.
Entity Central Index Key 0000097745
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 04-2209186
Entity Address, Address Line One 168 Third Avenue
Entity Address, City or Town Waltham
Entity Address, State or Province MA
Entity Address, Postal Zip Code 02451
City Area Code 781
Local Phone Number 622-1000
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer true
Pre-commencement Issuer Tender Offer false
Common Stock [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Common Stock, $1.00 par value
Trading Symbol TMO
Security Exchange Name NYSE
0.750% Notes due 2024 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.750% Notes due 2024
Trading Symbol TMO 24A
Security Exchange Name NYSE
0.125% Notes due 2025 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.125% Notes due 2025
Trading Symbol TMO 25B
Security Exchange Name NYSE
2.000% Notes due 2025 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 2.000% Notes due 2025
Trading Symbol TMO 25
Security Exchange Name NYSE
1.400% Notes due 2026 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.400% Notes due 2026
Trading Symbol TMO 26A
Security Exchange Name NYSE
3.200% Notes due 2026 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 3.200% Notes due 2026
Trading Symbol TMO 26B
Security Exchange Name NYSE
1.450% Notes due 2027 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.450% Notes due 2027
Trading Symbol TMO 27
Security Exchange Name NYSE
1.750% Notes due 2027 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.750% Notes due 2027
Trading Symbol TMO 27B
Security Exchange Name NYSE
0.500% Notes due 2028 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.500% Notes due 2028
Trading Symbol TMO 28A
Security Exchange Name NYSE
1.375% Notes due 2028 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.375% Notes due 2028
Trading Symbol TMO 28
Security Exchange Name NYSE
1.950% Notes due 2029 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.950% Notes due 2029
Trading Symbol TMO 29
Security Exchange Name NYSE
0.875% Notes due 2031 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.875% Notes due 2031
Trading Symbol TMO 31
Security Exchange Name NYSE
2.375% Notes due 2032 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 2.375% Notes due 2032
Trading Symbol TMO 32
Security Exchange Name NYSE
3.650% Notes due 2034 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 3.650% Notes due 2034
Trading Symbol TMO 34
Security Exchange Name NYSE
2.875% Notes due 2037 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 2.875% Notes due 2037
Trading Symbol TMO 37
Security Exchange Name NYSE
1.500% Notes due 2039 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.500% Notes due 2039
Trading Symbol TMO 39
Security Exchange Name NYSE
1.875% Notes due 2049 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.875% Notes due 2049
Trading Symbol TMO 49
Security Exchange Name NYSE
XML 8 form8-k_htm.xml IDEA: XBRL DOCUMENT 0000097745 2023-10-17 2023-10-17 0000097745 us-gaap:CommonStockMember 2023-10-17 2023-10-17 0000097745 tmo:Zero875NotesDue2031Member 2023-10-17 2023-10-17 0000097745 tmo:Zero125NotesDue2025Member 2023-10-17 2023-10-17 0000097745 tmo:One500NotesDue2039Member 2023-10-17 2023-10-17 0000097745 tmo:Three650NotesDue2034Member 2023-10-17 2023-10-17 0000097745 tmo:Zero750NotesDue2024Member 2023-10-17 2023-10-17 0000097745 tmo:Three200NotesDue2026Member 2023-10-17 2023-10-17 0000097745 tmo:One750NotesDue2027Member 2023-10-17 2023-10-17 0000097745 tmo:One450NotesDue2027Member 2023-10-17 2023-10-17 0000097745 tmo:Two375NotesDue2032Member 2023-10-17 2023-10-17 0000097745 tmo:Two875NotesDue2037Member 2023-10-17 2023-10-17 0000097745 tmo:One875NotesDue2049Member 2023-10-17 2023-10-17 0000097745 tmo:One400NotesDue2026Member 2023-10-17 2023-10-17 0000097745 tmo:One950NotesDue2029Member 2023-10-17 2023-10-17 0000097745 tmo:Two000NotesDue2025Member 2023-10-17 2023-10-17 0000097745 tmo:One375NotesDue2028Member 2023-10-17 2023-10-17 0000097745 tmo:Zero500NotesDue2028Member 2023-10-17 2023-10-17 false 0000097745 8-K 2023-10-17 THERMO FISHER SCIENTIFIC INC. DE 001-08002 04-2209186 168 Third Avenue Waltham MA 02451 781 622-1000 false false true false Common Stock, $1.00 par value TMO NYSE 0.750% Notes due 2024 TMO 24A NYSE 0.125% Notes due 2025 TMO 25B NYSE 2.000% Notes due 2025 TMO 25 NYSE 1.400% Notes due 2026 TMO 26A NYSE 3.200% Notes due 2026 TMO 26B NYSE 1.450% Notes due 2027 TMO 27 NYSE 1.750% Notes due 2027 TMO 27B NYSE 0.500% Notes due 2028 TMO 28A NYSE 1.375% Notes due 2028 TMO 28 NYSE 1.950% Notes due 2029 TMO 29 NYSE 0.875% Notes due 2031 TMO 31 NYSE 2.375% Notes due 2032 TMO 32 NYSE 3.650% Notes due 2034 TMO 34 NYSE 2.875% Notes due 2037 TMO 37 NYSE 1.500% Notes due 2039 TMO 39 NYSE 1.875% Notes due 2049 TMO 49 NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 18 22 1 false 17 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://thermofisher.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports form8-k.htm tmo-20231017.xsd tmo-20231017_def.xml tmo-20231017_lab.xml tmo-20231017_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "tmo", "nsuri": "http://thermofisher.com/20231017", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "tmo-20231017.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "tmo-20231017_def.xml" ] }, "labelLink": { "local": [ "tmo-20231017_lab.xml" ] }, "presentationLink": { "local": [ "tmo-20231017_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 16, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 18, "entityCount": 1, "segmentCount": 17, "elementCount": 50, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 70 }, "report": { "R1": { "role": "http://thermofisher.com/role/DocumentAndEntityInformation", "longName": "000100 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c20231017to20231017", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c20231017to20231017", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "tmo_One875NotesDue2049Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "One875NotesDue2049Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "1.875% Notes due 2049 [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "tmo_Two000NotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Two000NotesDue2025Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "2.000% Notes due 2025 [Member]" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "tmo_Three650NotesDue2034Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Three650NotesDue2034Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "3.650% Notes due 2034 [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "tmo_Two375NotesDue2032Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Two375NotesDue2032Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "2.375% Notes due 2032 [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "tmo_One400NotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "One400NotesDue2026Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "1.400% Notes due 2026 [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "tmo_Two875NotesDue2037Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Two875NotesDue2037Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "2.875% Notes due 2037 [Member]" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "tmo_One950NotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "One950NotesDue2029Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "1.950% Notes due 2029 [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsLineItems", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "tmo_One750NotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "One750NotesDue2027Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "1.750% Notes due 2027 [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "tmo_Zero125NotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Zero125NotesDue2025Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "0.125% Notes due 2025 [Member]" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "tmo_Zero875NotesDue2031Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Zero875NotesDue2031Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "0.875% Notes due 2031 [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "tmo_Three200NotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Three200NotesDue2026Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "3.200% Notes due 2026 [Member]" } } }, "auth_ref": [] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "tmo_One450NotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "One450NotesDue2027Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "1.450% Notes due 2027 [Member]" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "tmo_Zero500NotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Zero500NotesDue2028Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "0.500% Notes due 2028 [Member]" } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "tmo_One500NotesDue2039Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "One500NotesDue2039Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "1.500% Notes due 2039 [Member]" } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityListingsTable", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "tmo_One375NotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "One375NotesDue2028Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "1.375% Notes due 2028 [Member]" } } }, "auth_ref": [] }, "tmo_Zero750NotesDue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://thermofisher.com/20231017", "localname": "Zero750NotesDue2024Member", "presentation": [ "http://thermofisher.com/role/DocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "0.750% Notes due 2024 [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000950157-23-001058-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950157-23-001058-xbrl.zip M4$L#!!0 ( -M(45?(/HQL0AD !Q4 * 97@Y.2TQ+FAT;>U<:7/; M1K;]_JK>?^CG+&-7@=3B+9:<5%$497%,B1I2BLL?FT"3[!@$�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end